Skip to Main Content

Paper Details

Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response.
Clin Cancer Res
41
2017
Author NameAffiliation
Manish A ShahWeill Cornell Medical College
Allyson J OceanWeill Cornell Medical College
Nasser K AltorkiWeill Cornell Medical College
Agnes VialeMemorial Sloan-Kettering Cancer Center
  • 1 - 4

Datasets

Release 1.2